Latest perspectives on the benefits of neoadjuvant therapy for patients with advanced gastric cancer

Treatment for gastric cancer has multiple approaches and options across the world. Standard treatment Asian population comprises D2-gastrectomy adjuvant chemotherapy. However, in Europe North America, clinical trials have shown that perioperative chemotherapy, given to patients before surgery, could improve resection survival rates significantly. Most recent studies also discussed advantages of doublet vs. triplet chemotherapy regimens. Furthermore, researchers been comparing effects chemoradiotherapy as opposed alone. The specific previously stated therapy options, well any novel treatments, should be researched more thoroughly future.